Search Results - "Roccuzzo, Gabriele"

Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas.

Authors: Fava, Paolo Roccuzzo, Gabriele Macagno, Nicole et al.

Source: JEADV Clinical Practice. Dec2024, Vol. 3 Issue 5, p1447-1453. 7p.

Synchronous occurrence of primary cutaneous B‐cell lymphoma and cutaneous Rosai–Dorfman disease in distinct lesions: A unique association.

Authors: Roccuzzo, Gabriele Avallone, Gianluca Cavallo, Francesco et al.

Source: Journal of Cutaneous Pathology. Jan2024, Vol. 51 Issue 1, p7-10. 4p.

Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis.

Authors: Roccuzzo, Gabriele Repetto, Federica Giordano, Silvia et al.

Source: Experimental Dermatology. Jul2024, Vol. 33 Issue 7, p1-6. 6p.

Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study.

Authors: Michelerio, Andrea Roccuzzo, Gabriele Neri, Iria et al.

Source: JEADV Clinical Practice. Jan2026, p1. 7p. 2 Illustrations, 2 Charts.

Mixed purpuric and maculopapular eruption in a 70-year-old woman.

Authors: Avallone, Gianluca Trucco, Giulia Vocino Roccuzzo, Gabriele et al.

Source: Clinical & Experimental Dermatology. Apr2024, Vol. 49 Issue 4, p430-433. 4p.

Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

Authors: Pravisano, Federico Costa, Jacopo Marchi, Lorenzo De et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1802. 15p.

New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma.

Authors: Spagnoletti, Andrea Di Guardo, Lorenza Indini, Alice et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1669. 15p.

Psoriasis in Childbearing Age: A Real-Life, Retrospective, Single-Center Study on Anti-IL17 and IL-23 Agents.

Authors: Borriello, Silvia Roccuzzo, Gabriele Dapavo, Paolo et al.

Source: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6401. 12p.

Retinoid-associated myopia in dermatologic patients: a systematic review.

Authors: Roccuzzo, Gabriele Tibaldi, Tommaso Cavallo, Francesco et al.

Source: Cutaneous & Ocular Toxicology. Dec2022, Vol. 41 Issue 4, p318-322. 5p.

Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?

Authors: Roccuzzo, Gabriele Rozzo, Giulia Burzi, Lorenza et al.

Source: Dermatologic Therapy. Nov2022, Vol. 35 Issue 11, p1-4. 4p.

Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience.

Authors: Roccuzzo, Gabriele Macagno, Nicole Grignani, Pietro et al.

Source: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 17, p5238. 12p.

Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma.

Authors: Roccuzzo, Gabriele Fava, Paolo Astrua, Chiara et al.

Source: Cancers. Sep2024, Vol. 16 Issue 17, p3095. 11p.

Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.

Authors: Roccuzzo, Gabriele Mastorino, Luca Susca, Sara et al.

Source: Clinical & Experimental Dermatology. Apr2023, Vol. 48 Issue 4, p379-381. 3p. 1 Chart.

Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association.

Authors: Roccuzzo, Gabriele Cavallo, Francesco Avallone, Gianluca et al.

Source: Dermatologic Therapy. Apr2022, Vol. 35 Issue 4, p1-2. 2p.

Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?

Authors: Cavallo, Francesco Roccuzzo, Gabriele Avallone, Gianluca et al.

Source: Dermatologic Therapy. Jul2022, Vol. 35 Issue 7, p1-2. 2p.

Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?

Authors: Mastorino, Luca Roccuzzo, Gabriele Dapavo, Paolo et al.

Source: Dermatologic Therapy. Sep2022, Vol. 35 Issue 9, p1-3. 3p.

Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center.

Authors: Roccuzzo, Gabriele Giordano, Silvia Granato, Thomas et al.

Source: Cancers. Aug2023, Vol. 15 Issue 15, p3772. 14p.

Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatment.

Authors: Marchisio, Sara Ricci, Alessia Andrea Roccuzzo, Gabriele et al.

Source: Journal of Translational Medicine. 11/28/2024, Vol. 22 Issue 1, p1-11. 11p.

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas.

Authors: Lin, Liyun Roccuzzo, Gabriele Yakymiv, Yuliya et al.

Source: Cells (2073-4409). Feb2025, Vol. 14 Issue 4, p309. 17p.

Cutaneous and Lymphangitic Infection Caused by Purpureocillium lilacinum in Immunocompromised Patients: A Case Report with a Narrative Review of the Literature.

Authors: Lupia, Tommaso Sarda, Cristina Canta, Francesca et al.

Source: Life (2075-1729). Sep2025, Vol. 15 Issue 9, p1453. 13p.